Case Type: Mergers & Acquisitions

MRC Global Inc. (NYSE: MRC) related to its merger with DNOW, Inc. in which MRC shareholders will receive 0.9489 shares of DNOW common stock for each share of MRC common stock.

IGM Biosciences, Inc. (NASDAQ: IGMS) related to its merger to Concentra Biosciences, LLC for $1.247 in cash per share of IGM Biosciences common stock, plus one non-tradeable contingent value right, which represents the right to receive: (i) 100% of the closing net cash of IGM Biosciences in excess of $82.0 million; and (ii) 80% of any … Read more

Big 5 Sporting Goods Corp. (NASDAQ: BGFV) related to its sale to a partnership comprised of Worldwide Golf and Capitol Hill for $1.45 share in cash without interest to Big 5 Sporting Goods shareholders.

GMS Inc. (NYSE: GMS) related to its sale to SRS Distribution for $110.00 per share without interest to GMS shareholders.

Couchbase, Inc. (NASDAQ: BASE) related to its sale to Haveli Investments for $24.50 per share in cash without interest to Couchbase shareholders.

SpartanNash Company (NASDAQ: SPTN) related to its sale to C&S Wholesale Grocers for $26.90 per share in cash without interest to SpartanNash shareholders.

Enzo Biochem, Inc. (OTCMKTS: ENZB) related to its sale to Battery Ventures for $0.70 per share in cash without interest to Enzo shareholders.

DNOW Inc. (NYSE: DNOW) related to its merger with MRC Global Inc. Upon completion of the proposed transaction, current DNOW shareholders will own approximately 56.5% of the combined company on a fully diluted basis.

Sage Therapeutics, Inc. (NASDAQ: SAGE) related to its sale to Supernus Pharmaceuticals, Inc. Upon completion of the proposed transaction, current Sage shareholders will receive $8.50 per share in cash, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash payable (i) $0.50 the first commercial sale of the drug Zurzuvae … Read more

Turnstone Biologics Corp. (NASDAQ: TSBX) related to its sale to XOMA Royalty Corporation in which existing Turnstone shareholders will receive $0.34 in cash per share and one non-transferable contingent value right.